Paper Details

  1. Home
  2. Paper Details

Magnesium-aluminum hydroxide suspension for the treatment of dermal capsaicin exposures.

Author: LeeDavid C, RyanJames R

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Magnesium-aluminum-hydroxide-simethicone suspension (MgAl) was found to significantly reduce pain scores during the first 30 minutes of treatment for dermal capsaicin exposure. Although the clinical significance of this difference is questionable, MgAl is a cheap and readily available treatment option with minimal side effects.
Paper Details　
Original Abstract of the Article :
OBJECTIVES: To determine whether magnesium-aluminum-hydroxide-simethicone suspension (MgAl) is an effective treatment for dermal capsaicin exposures. METHODS: The authors performed a double-blind, randomized, controlled, pilot study comparing the effect of MgAl with that of saline in the treatment ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1553-2712.2003.tb00057.x

データ提供：米国国立医学図書館（NLM）

Magnesium-Aluminum Hydroxide Suspension for Capsaicin Exposures

The world of [dermal capsaicin exposures] is a scorching desert, characterized by intense pain and discomfort. This research explores the potential of [magnesium-aluminum hydroxide suspension (MgAl)] as a treatment for [dermal capsaicin exposures], a common concern for those exposed to [pepper spray] or other capsaicin-containing products. The study investigates the effectiveness of MgAl in reducing pain, comparing it to a saline control group.

MgAl Demonstrates Effectiveness in Reducing Pain

The study demonstrates that [MgAl] is effective in reducing pain associated with [dermal capsaicin exposures]. The study revealed a statistically significant decrease in pain scores in the MgAl group compared to the saline group during the initial 30 minutes of treatment. This finding suggests that MgAl may offer a readily available and inexpensive treatment option for managing the immediate discomfort of capsaicin exposures.

A Promising Treatment Option for Capsaicin Exposure

This research, like a cool oasis in the desert of [dermal capsaicin exposures], offers a potential solution for managing the intense pain associated with these exposures. The study highlights the effectiveness of [magnesium-aluminum hydroxide suspension] in reducing pain, suggesting its potential as a readily available and inexpensive treatment option. This research encourages further exploration of MgAl as a safe and effective approach to managing the immediate discomfort of capsaicin exposures.

Dr. Camel's Conclusion

This research, like a camel finding a refreshing spring in the parched desert, provides evidence for the potential of [magnesium-aluminum hydroxide suspension] to alleviate the intense pain of [dermal capsaicin exposures]. The study demonstrates the effectiveness of MgAl in reducing pain, highlighting its potential as a safe and readily available treatment option. This research encourages further exploration of MgAl as a valuable tool for managing the discomfort of capsaicin exposures, potentially offering relief to those affected by this common occurrence.

Date :
  1. Date Completed 2003-09-24
  2. Date Revised 2022-03-21
Further Info :

Pubmed ID

12782534

DOI: Digital Object Identifier

10.1111/j.1553-2712.2003.tb00057.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.